85 related articles for article (PubMed ID: 12500070)
1. Ziprasidone-associated galactorrhea in a female teenager.
Jordan MP
J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):4-5. PubMed ID: 12500070
[No Abstract] [Full Text] [Related]
2. Ziprasidone-induced galactorrhea: a case report.
Kopecek M; Bares M; Mohr P
Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
[TBL] [Abstract][Full Text] [Related]
3. Ziprasidone-associated galactorrhea in an adolescent female.
Saldaña SN; Delgado SV
J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):259-60. PubMed ID: 17489723
[No Abstract] [Full Text] [Related]
4. D2-blockade and possible ziprasidone-induced galactorrhea.
Ramadan M; Khan A; Preskorn S
Int Clin Psychopharmacol; 2005 Mar; 20(2):113-4. PubMed ID: 15729088
[TBL] [Abstract][Full Text] [Related]
5. Possible ziprasidone-induced mania.
Larson MF; Hauser A
J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
[No Abstract] [Full Text] [Related]
6. Ziprasidone and mania.
Barnett MS
J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):380. PubMed ID: 15187796
[No Abstract] [Full Text] [Related]
7. The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.
Eker SS; Sarandol A; Akkaya C; Sivrioglu EY; Kirli S
J Psychopharmacol; 2009 Nov; 23(8):993-6. PubMed ID: 18635710
[TBL] [Abstract][Full Text] [Related]
8. Ziprasidone-induced acute laryngeal dystonia.
Duggal HS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):970; author reply 971. PubMed ID: 17343967
[No Abstract] [Full Text] [Related]
9. Ziprasidone-induced hyperprolactinemia: a case report.
Citil DY; Selçuk E; Karlidağ R; Unal S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):905-6. PubMed ID: 18276052
[No Abstract] [Full Text] [Related]
10. Serotonin syndrome caused by ziprasidone alone.
Lin PY; Hong CJ; Tsai SJ
Psychiatry Clin Neurosci; 2010 Jun; 64(3):338-9. PubMed ID: 20602736
[No Abstract] [Full Text] [Related]
11. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
Tsai CF; Tsai SJ; Hwang JP
Int J Geriatr Psychiatry; 2005 Aug; 20(8):797-9. PubMed ID: 16035110
[No Abstract] [Full Text] [Related]
12. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
Chen HK; Chen CK; Tzeng NS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
[No Abstract] [Full Text] [Related]
13. The highest intentional ziprasidone overdose was not fatal.
Prieto T; Benabarre A; Bernardo M
Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953
[No Abstract] [Full Text] [Related]
14. Urticaria and angio-oedema due to ziprasidone.
Akkaya C; Sarandol A; Aydogan K; Kirli S
J Psychopharmacol; 2007 Jul; 21(5):550-2. PubMed ID: 17446198
[TBL] [Abstract][Full Text] [Related]
15. High-dose ziprasidone-induced acute dystonia.
Rosenfield PJ; Girgis RR; Gil R
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
[TBL] [Abstract][Full Text] [Related]
16. Risperidone-associated galactorrhea in a male teenager.
Gupta S; Frank B; Madhusoodanan S
J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):504-5. PubMed ID: 11349691
[No Abstract] [Full Text] [Related]
17. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
Montejo AL; Rico-Villademoros F;
J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
[No Abstract] [Full Text] [Related]
18. Ziprasidone-induced oculogyric crisis.
Ramos AE; Shytle RD; Silver AA; Sanberg PR
J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1013-4. PubMed ID: 12964566
[No Abstract] [Full Text] [Related]
19. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
Bentley ML; Biscardi FH; Butcher C; Levitov A
Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
[No Abstract] [Full Text] [Related]
20. Ziprasidone-induced tardive dyskinesia in a patient without known risk factors.
Sinha P; Rao R; Sharan P
Natl Med J India; 2007; 20(5):271-2. PubMed ID: 18254531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
